Status:
COMPLETED
Circadian Rhythms and Cardiovascular Risk
Lead Sponsor:
Oregon Health and Science University
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The purpose of this study is to understand how behaviors and the effects of the body's internal clock (called the circadian pacemaker) affect the control of the heart and blood pressure. People with ...
Eligibility Criteria
Inclusion
- BMI less than 40
- Moderate to severe OSA (AHI)\>15
- No current or previous pharmacological treatment for hypertension
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 9 2020
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT02202811
Start Date
August 1 2014
End Date
March 9 2020
Last Update
July 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239